2.Hot issues of immunology in viral hepatitis C.
Chinese Journal of Hepatology 2009;17(7):490-493
Animals
;
Antigens, CD
;
immunology
;
Cytokines
;
metabolism
;
Hepacivirus
;
immunology
;
Hepatitis C
;
immunology
;
prevention & control
;
virology
;
Hepatitis C Antibodies
;
biosynthesis
;
immunology
;
Hepatitis C Antigens
;
immunology
;
Humans
;
Killer Cells, Natural
;
immunology
;
T-Lymphocytes
;
immunology
;
metabolism
;
T-Lymphocytes, Regulatory
;
immunology
;
metabolism
;
Viral Proteins
;
immunology
3.KCTD9, a novel potassium channel related gene, was highly expressed in hepatic NK cells and T cells of fulminant hepatitis mice induced by MHV-3.
Yao-Yong ZHOU ; Yong ZOU ; Tao CHEN ; Hong-wu WANG ; Mei-fang HAN ; Bin PI ; Wei-ming YAN ; Dong XI ; Jia-quan HUANG ; Xiao-ping LUO ; Qin NING
Chinese Journal of Hepatology 2011;19(11):833-837
OBJECTIVETo explore the mechanisms of a novel potassium channel gene named KCTD9 (potassium channel tetramerization domain containing 9) in model of fulminant viral hepatitis induced by murine hepatitis virus 3 (MHV-3).
METHODS78 BALB/cJ mice(6 male) were randomly and equally assigned to two groups, model group of fulminant viral hepatitis induced by MHV3 and its control. 75 C3H/HeJ female mice were done into two groups, 39 for model group of chronic hepatitis induced by MHV3, 36 for control. Various samples including spleen, liver and lymphocytes from mice of two model groups and the controls were examined for KCTD9 expression by real time quantitative PCR and Immunohistochemistry. Independent-samples T test or one-way ANOVA were carried out in different groups.
RESULTSIncreased expressions of KCTD9 mRNA was observed in livers of both model mice of fulminant viral hepatitis and chronic hepatitis. Compared with the control mice, the expressions of KCTD9 mRNA were up-regulated by 577.1-, 8.8-, 59.4- and 10.8-fold in hepatic NK cells, CD4+ T cells, CD8+ T cells and splenic NK cells respectively in model mice of fulminant viral hepatitis 48 hr post MHV-3 infection, whereas down-regulation by 43% and 69% in splenic CD4 + T cells and CD8+ T cells were found respectively. In contrast, in model mice of chronic viral hepatitis the expressions of KCTD9 mRNA were down-regulated by 71% and 51% in hepatic CD4+ T cells and NK cells, respectively. The expression of KCTD9 protein was mainly evidenced in infiltrative mononuclear cells of liver as shown by immunohistochemistry. Basal expression was also investigated and showed constitutive expression of KCTD9 in brain, thymus and other organs in BALB/cJ mice.
CONCLUSIONA novel potassium channel gene KCTD9 was highly expressed in hepatic NK cells and T cells of fulminant hepatitis mice induced by MHV-3.
Animals ; CD4-Positive T-Lymphocytes ; immunology ; metabolism ; Female ; Hepatitis, Viral, Animal ; immunology ; metabolism ; virology ; Killer Cells, Natural ; immunology ; metabolism ; Liver ; metabolism ; virology ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C3H ; Murine hepatitis virus ; Potassium Channels ; genetics ; metabolism
4.Frequency of Killer Cell Immunoglobulin-like Receptors (KIRs) in Korean Patients with Chronic HCV Infection.
Pil Soo SUNG ; Hee Baeg CHOI ; Su Yeon KIM ; Sung Woo HONG ; Chung Hwa PARK ; Myeong Jun SONG ; Sung Won LEE ; Chan Ran YOO ; Sang Wook CHOI ; Nam Ik HAN ; Tai Gyu KIM ; Seung Kew YOON
Journal of Korean Medical Science 2011;26(11):1483-1488
Natural killer (NK) cells play an important role in innate immunity, especially in the response to viral infections, such as hepatitis C virus (HCV). Killer cell immunoglobulin-like receptors (KIRs) are the primary receptors of NK cells that mediate innate immunity. KIRs are also involved in acquired immunity, because some KIRs are expressed on the surface of certain subsets of T cells. In this study, the frequency of KIR genes, HLA-C allotypes, and combinations of KIR genes with their HLA-C ligands were evaluated in two different groups of the Korean population: controls and patients with chronic HCV infection. The study population consisted of 147 Korean patients with chronic HCV infection. The frequency of KIR2DS2 in patients with chronic HCV infection was 9.5% which was significantly lower than 19.5% of the control (P < 0.01). However, there were no significant differences in the frequency of other KIR genes, HLA-C allotypes or different combinations of KIR genes with their HLA-C ligands. This study can contribute to the further prospective study with a larger scale, suggesting the assumption that KIR2DS2 might aid in HCV clearance by enhancing both the innate and acquired immune responses of people in Korea.
Adult
;
Aged
;
Female
;
Genes, MHC Class I
;
Genotype
;
HLA-C Antigens/genetics
;
Hepacivirus/immunology
;
Hepatitis C, Chronic/*genetics/immunology
;
Humans
;
Killer Cells, Natural/immunology/virology
;
Male
;
Middle Aged
;
Receptors, KIR/*genetics/immunology
;
Republic of Korea
;
T-Lymphocyte Subsets/immunology
5.Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
Qingqing CAI ; Kailin CHEN ; Ken H YOUNG
Experimental & Molecular Medicine 2015;47(1):e133-
Epstein-Barr virus, a ubiquitous human herpesvirus, can induce both lytic and latent infections that result in a variety of human diseases, including lymphoproliferative disorders. The oncogenic potential of Epstein-Barr virus is related to its ability to infect and transform B lymphocytes into continuously proliferating lymphoblastoid cells. However, Epstein-Barr virus has also been implicated in the development of T/natural killer cell lymphoproliferative diseases. Epstein-Barr virus encodes a series of products that mimic several growth, transcription and anti-apoptotic factors, thus usurping control of pathways that regulate diverse homeostatic cellular functions and the microenvironment. However, the exact mechanism by which Epstein-Barr virus promotes oncogenesis and inflammatory lesion development remains unclear. Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases often have overlapping clinical symptoms as well as histologic and immunophenotypic features because both lymphoid cell types derive from a common precursor. Accurate classification of Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases is a prerequisite for appropriate clinical management. Currently, the treatment of most T/natural killer cell lymphoproliferative diseases is less than satisfactory. Novel and targeted therapies are strongly required to satisfy clinical demands. This review describes our current knowledge of the genetics, oncogenesis, biology, diagnosis and treatment of Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
Cell Transformation, Viral
;
Epstein-Barr Virus Infections/*complications
;
Herpesvirus 4, Human/*physiology
;
Humans
;
Killer Cells, Natural/immunology/metabolism/*pathology/*virology
;
Lymphoproliferative Disorders/diagnosis/*etiology/therapy
;
T-Lymphocytes/immunology/metabolism/*pathology/*virology
6.Modeling EBV infection and pathogenesis in new-generation humanized mice.
Shigeyoshi FUJIWARA ; Ken Ichi IMADOME ; Masami TAKEI
Experimental & Molecular Medicine 2015;47(1):e135-
The development of highly immunodeficient mouse strains has allowed the reconstitution of functional human immune system components in mice. New-generation humanized mice generated in this manner have been extensively used for modeling viral infections that are exclusively human tropic. Epstein-Barr virus (EBV)-infected humanized mice reproduce cardinal features of EBV-associated B-cell lymphoproliferative disease and EBV-associated hemophagocytic lymphohistiocytosis (HLH). Erosive arthritis morphologically resembling rheumatoid arthritis (RA) has also been recapitulated in these mice. Low-dose EBV infection of humanized mice results in asymptomatic, persistent infection. Innate immune responses involving natural killer cells, EBV-specific adaptive T-cell responses restricted by human major histocompatibility and EBV-specific antibody responses are also elicited in humanized mice. EBV-associated T-/natural killer cell lymphoproliferative disease, by contrast, can be reproduced in a distinct mouse xenograft model. In this review, recent findings on the recapitulation of human EBV infection and pathogenesis in these mouse models, as well as their application to preclinical studies of experimental anti-EBV therapies, are described.
Animals
;
Disease Models, Animal
;
Epstein-Barr Virus Infections/complications/immunology/*virology
;
Herpesvirus 4, Human/*physiology
;
Heterografts
;
Humans
;
Killer Cells, Natural/pathology/virology
;
Lymphoproliferative Disorders/etiology
;
Mice
;
Mice, SCID
;
T-Lymphocytes/pathology/virology
7.Characteristics of peripheral blood lymphocyte immune subsets in patients with chronic active Epstein-Barr virus infection.
Yan XING ; Hong-mei SONG ; Tai-sheng LI ; Zhi-feng QIU ; Xiao-yan WU ; Wei WANG ; Min WEI
Chinese Journal of Pediatrics 2009;47(6):441-445
OBJECTIVETo study the characteristics of the peripheral blood lymphocyte subsets in pediatric patients with chronic active EBV (CAEBV) infection.
METHODFlow cytometry was used to detect the peripheral blood NK, B, T lymphocyte subsets and the functional, regulatory, naïve, memory and activatory subsets of T lymphocytes in 10 pediatric patients with CAEBV infection, 13 pediatric patients with acute Epstein-Barr virus infection (AEBV) and 12 healthy children in our hospital between March 2004 and April 2008.
RESULTCompared with AEBV group, the number of white blood cells [3325 x 10(6)/L (median, just the same as the following)], lymphocytes (1078 x 10(6)/L), NK cells (68 x 10(6)/L), B cells (84 x 10(6)/L), total T cells (684 x 10(6)/L), CD4+ T cells (406 x 10(6)/L) and CD8+ T cells (295 x 10(6)/L) in CAEBV patients were lower (P<0.05). The functional subset of the CD4+ T cells in CAEBV group (94.5%) was lower than those of the healthy control group (98.7%) (P<0.05), but was still higher than those of AEBV group (74.0%) (P<0.05). While the functional subset of the CD8+ T cells in CAEBV (40.7%) was not dramatically different from the healthy control group (48.3%), but was still higher than that of AEBV group (21.0%) (P<0.05). Although the regulatory subset in CAEBV group (5.0%) was higher than the health control group (4.6%) (P<0.05), but lower than AEBV group (5.8%) (P<0.05). In CAEBV, the proportion of CD4+/CD8+ naïve T cells (32.3%/37.5%) was lower than that of normal group (58.3%/56.6%) (P<0.05), but the proportion of CD4+/CD8+ effective memory T cells in CAEBV group (23.9%/15.1%) was lower than that in AEBV group (36.5%/69.8%) (P<0.05), while the proportion of CD8+ fake naïve T cells in CAEBV (17.5%) was higher than the other 2 groups (P<0.05). The CD8+ activatory subset in CAEBV group (84.4%/34.0%) was higher than that of the healthy control group (44.1%/16.7%) (P<0.05), but still lower than AEBV group (96%/95%) (P<0.05).
CONCLUSIONThere is an imbalance in lymphocyte subsets and disturbance in cellular immunity in CAEBV patients, which may be associated with EBV chronic active infection. Detecting the peripheral haematologic parameters and lymphocyte subsets may be helpful in the diagnosis and the differential diagnosis of CAEBV.
Adolescent ; CD4-CD8 Ratio ; CD4-Positive T-Lymphocytes ; CD8-Positive T-Lymphocytes ; Case-Control Studies ; Child ; Epstein-Barr Virus Infections ; blood ; immunology ; virology ; Female ; Flow Cytometry ; Herpesvirus 4, Human ; Humans ; Killer Cells, Natural ; Lymphocyte Subsets ; immunology ; Male
8.Hypersensitivity to Mosquito Bites Associated with Natural Killer Cell-derived Large Granular Lymphocyte Lymphocytosis: A Case Report in Korea.
Joo Seop CHUNG ; Ho Jin SHIN ; Eun Yup LEE ; Goon Jae CHO
The Korean Journal of Internal Medicine 2003;18(1):50-52
Hypersensitivity to mosquito bites (HMB) is characterized by intense skin reactions at bite sites. The pathogenesis of HMB might be related to clonal lymphoproliferation of Epstein-Barr virus DNA-positive natural killer (NK) cells. We report the first case of HMB possibly associated with NK cell-derived large granular lymphocyte (NK-LGL) lymphocytosis in Korea.
Adult
;
Animals
;
Base Sequence
;
*Culicidae
;
Epstein-Barr Virus Infections/*complications/diagnosis
;
Humans
;
Hypersensitivity/*etiology/virology
;
Insect Bites and Stings/*complications/immunology
;
Killer Cells, Natural/*immunology/pathology
;
Korea
;
Lymphocytosis/*complications/pathology
;
Male
;
Molecular Sequence Data
;
Polymerase Chain Reaction
;
Prognosis
;
Risk Assessment
9.Safety of in vitro amplified HLA-haploidentical donor immune cell infusions for childhood malignancies.
Fei ZHANG ; Xiao-Fei SUN ; Yong-Qiang LI ; Zi-Jun ZHEN ; Hai-Xia ZHENG ; Jia ZHU ; Qi-Jing WANG ; Su-Ying LU ; Jia HE ; Juan WANG ; Ke PAN ; Rui-Qing CAI ; Yan CHEN ; De-Sheng WENG ; Fei-Fei SUN ; Jian-Chuan XIA
Chinese Journal of Cancer 2013;32(12):661-666
In vitro amplified human leukocyte antigen (HLA)-haploidentical donor immune cell infusion (HDICI) is not commonly used in children. Therefore, our study sought to evaluate its safety for treating childhood malignancies. Between September 2011 and September 2012, 12 patients with childhood malignancies underwent HDICI in Sun Yat-sen University Cancer Center. The median patient age was 5.1 years (range, 1.7-8.4 years). Of the 12 patients, 9 had high-risk neuroblastoma (NB) [7 showed complete response (CR), 1 showed partial response (PR), and 1 had progressive disease (PD) after multi-modal therapies], and 3 had Epstein-Barr virus (EBV)-positive lymphoproliferative disease (EBV-LPD). The 12 patients underwent a total of 92 HDICIs at a mean dose of 1.6×10(8) immune cells/kg body weight: 71 infusions with natural killer (NK) cells, 8 with cytokine-induced killer (CIK) cells, and 13 with cascade primed immune cells (CAPRIs); 83 infusions with immune cells from the mothers, whereas 9 with cells from the fathers. Twenty cases (21.7%) of fever, including 6 cases (6.5%) accompanied with chills and 1 (1.1%) with febrile convulsion, occurred during infusions and were alleviated after symptomatic treatments. Five cases (5.4%) of mild emotion changes were reported. No other adverse events occurred during and after the completion of HDIDIs. Neither acute nor chronic graft versus host disease (GVHD) was observed following HDICIs. After a median of 5.0 months (range, 1.0-11.5 months) of follow-up, the 2 NB patients with PR and PD developed PD during HDICIs. Of the other 7 NB patients in CR, 2 relapsed in the sixth month of HDICIs, and 5 maintained CR with disease-free survival (DFS) ranging from 4.5 to 11.5 months (median, 7.2 months). One EBV-LPD patient achieved PR, whereas 2 had stable disease (SD). Our results show that HDICI is a safe immunotherapy for childhood malignancies, thus warranting further studies.
Child
;
Child, Preschool
;
Cytokine-Induced Killer Cells
;
immunology
;
Epstein-Barr Virus Infections
;
therapy
;
Female
;
Follow-Up Studies
;
Graft vs Host Disease
;
etiology
;
Hematopoietic Stem Cell Transplantation
;
adverse effects
;
Humans
;
Immunotherapy, Adoptive
;
Infant
;
Killer Cells, Natural
;
immunology
;
Lymphoproliferative Disorders
;
therapy
;
virology
;
Male
;
Neuroblastoma
;
therapy
;
Transplantation, Homologous
;
Treatment Outcome
10.Novel Association of Killer Cell Immunoglobulin-like Receptor Genes with EBV-infectious Diseases in Children.
Li HUO ; ; Ming Yan JIANG ; Qiang LI ; Yi Ping ZHU ;
Biomedical and Environmental Sciences 2015;28(4):303-307
Killer cell immunoglobulin-like receptors (KIRs) which are mainly expressed on natural killer (NK) cells are implicated in many virus infections. However, it is unclear whether or not KIRs are associated with susceptibility to Epstein-Barr virus (EBV) infection related diseases. Therefore, the purpose of our study was to investigate possible correlation between polymorphisms of KIR genes and infectious mononucleosis (IM)/EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH). The polymorphisms of KIR genes were detected by polymerase chain reaction with sequence-specific primers (PCR-SSP). The results would contribute to clarify the association of KIRs with EBV induced diseases, and provide new insights into the role of NK cells and innate immune response against viral infections and/or subsequent progression.
Case-Control Studies
;
Child
;
Child, Preschool
;
China
;
Disease Progression
;
Female
;
Herpesvirus 4, Human
;
physiology
;
Humans
;
Immunity, Innate
;
Infectious Mononucleosis
;
genetics
;
immunology
;
virology
;
Killer Cells, Natural
;
immunology
;
metabolism
;
Lymphohistiocytosis, Hemophagocytic
;
genetics
;
immunology
;
virology
;
Male
;
Polymerase Chain Reaction
;
Polymorphism, Genetic
;
Receptors, KIR
;
genetics
;
metabolism